TW200501924A - Implantable pouch seeded with insulin-producing cells to treat diabetes - Google Patents

Implantable pouch seeded with insulin-producing cells to treat diabetes

Info

Publication number
TW200501924A
TW200501924A TW093109151A TW93109151A TW200501924A TW 200501924 A TW200501924 A TW 200501924A TW 093109151 A TW093109151 A TW 093109151A TW 93109151 A TW93109151 A TW 93109151A TW 200501924 A TW200501924 A TW 200501924A
Authority
TW
Taiwan
Prior art keywords
seeded
insulin
producing cells
treat diabetes
lumen
Prior art date
Application number
TW093109151A
Other languages
English (en)
Inventor
Alireza Rezania
Mark Zimmerman
Ragae M Ghabrial
Original Assignee
Lifescan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lifescan Inc filed Critical Lifescan Inc
Publication of TW200501924A publication Critical patent/TW200501924A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
TW093109151A 2003-04-02 2004-04-02 Implantable pouch seeded with insulin-producing cells to treat diabetes TW200501924A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/405,594 US20040197374A1 (en) 2003-04-02 2003-04-02 Implantable pouch seeded with insulin-producing cells to treat diabetes

Publications (1)

Publication Number Publication Date
TW200501924A true TW200501924A (en) 2005-01-16

Family

ID=32869169

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093109151A TW200501924A (en) 2003-04-02 2004-04-02 Implantable pouch seeded with insulin-producing cells to treat diabetes

Country Status (7)

Country Link
US (1) US20040197374A1 (zh)
EP (1) EP1466632A1 (zh)
JP (1) JP2004307505A (zh)
CN (1) CN100404074C (zh)
AU (1) AU2004201398A1 (zh)
CA (1) CA2462999A1 (zh)
TW (1) TW200501924A (zh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7399751B2 (en) * 1999-11-04 2008-07-15 Sertoli Technologies, Inc. Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells
CA2531022C (en) * 2003-07-03 2014-09-09 Jannette Dufour Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants
US20060153894A1 (en) * 2004-06-30 2006-07-13 Ragae Ghabrial Multi-compartment delivery system
JP4932832B2 (ja) * 2005-06-02 2012-05-16 アリゾナ・ボード・オブ・リージェンツ・オン・ビハーフ・オブ・ザ・ユニバーシティ・オブ・アリゾナ 血管予形成デバイスおよび関連する方法
US20080199507A1 (en) * 2005-06-17 2008-08-21 Rimon Therapeutics Ltd. Therapeutic Polymeric Pouch
DE102005042707A1 (de) * 2005-09-01 2007-03-08 Polymedics Innovations Gmbh Formkörper zur medizinischen Behandlung von Wunden
EP2129339B1 (en) * 2007-03-29 2015-03-04 Tyrx, Inc. Biodegradable, polymer coverings for breast implants
EP3290061B1 (en) * 2009-08-28 2020-06-10 Sernova Corporation Methods and devices for cellular transplantation
US8518440B2 (en) * 2010-12-21 2013-08-27 Confluent Surgical, Inc. Biodegradable osmotic pump implant for drug delivery
FR3014316B1 (fr) * 2013-12-10 2017-01-20 Defymed Organe bioartificiel
US11857670B2 (en) * 2014-06-06 2024-01-02 Nanovault Medical, Llc Implantable cellular and biotherapeutic agent delivery canister
US11857673B2 (en) 2014-06-06 2024-01-02 Nanovault Medical, Llc Implantable cellular and biotherapeutic agent delivery canister
US11857672B2 (en) 2014-06-06 2024-01-02 Nanovault Medical, Llc Implantable cellular and biotherapeutic agent delivery canister
EP3273949A4 (en) * 2015-03-23 2018-12-12 The Regents of The University of California Thin film cell encapsulation devices
AU2017366791B2 (en) * 2016-11-03 2021-01-21 Arizona Board Of Regents On Behalf Of The University Of Arizona Methods, systems, and implantable devices for enhancing blood glucose regulation
CA3042866A1 (en) 2016-11-03 2018-05-11 Klearchos K. Papas Encapsulation device systems with oxygen sensors with or without exogenous oxygen delivery
SG10202104564SA (en) 2016-11-03 2021-06-29 Univ Arizona Methods and systems for real-time assessment of cells in encapsulation devices pre-and post-transplantation
CN110121311B (zh) 2016-11-03 2023-01-06 代表亚利桑那大学的亚利桑那董事会 有或无氧气输送的堆叠组织包封装置的系统
WO2019004379A1 (ja) 2017-06-29 2019-01-03 富士フイルム株式会社 移植用チャンバーおよび移植用デバイス

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262055A (en) * 1992-10-19 1993-11-16 The University Of Utah Implantable and refillable biohybrid artificial pancreas
US5958404A (en) * 1994-04-13 1999-09-28 Research Corporation Technologies, Inc. Treatment methods for disease using co-localized cells and Sertoli cells obtained from a cell line
US6262255B1 (en) * 1995-04-05 2001-07-17 Biomm, Inc. Non-immunogenic, biocompatible macromolecular membrane compositions, and methods for making them
US6852330B2 (en) * 2000-12-21 2005-02-08 Depuy Mitek, Inc. Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
CA2365376C (en) * 2000-12-21 2006-03-28 Ethicon, Inc. Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
US20040062753A1 (en) * 2002-09-27 2004-04-01 Alireza Rezania Composite scaffolds seeded with mammalian cells

Also Published As

Publication number Publication date
CA2462999A1 (en) 2004-10-02
AU2004201398A1 (en) 2004-10-21
JP2004307505A (ja) 2004-11-04
CN1569236A (zh) 2005-01-26
CN100404074C (zh) 2008-07-23
US20040197374A1 (en) 2004-10-07
EP1466632A1 (en) 2004-10-13

Similar Documents

Publication Publication Date Title
TW200501924A (en) Implantable pouch seeded with insulin-producing cells to treat diabetes
WO2003092471A3 (en) Cell-seeded extracellular matrix grafts
WO2006074075A3 (en) Adipose-derived stem cells for tissue regeneration and wound healing
MX2010001061A (es) Reseleccion de celula en un sistema de comunicacion inalambrica.
EP2268809A4 (en) NUCLEAR REPROGRAMMING PROCESS
EP1799812A4 (en) EX VIVO CULTIVATION METHODS OF STEM CELLS AND PRECURSOR BY CO-CULTURE WITH MESENCHYMAL CELLS
MX2009004238A (es) Metodos y composiciones para tratamiento de defectos oseos con poblaciones de celulas de placenta.
MX2010000746A (es) Diferenciacion de celulas madre embrionarias humanas.
MX2010001335A (es) Diferenciacion de celulas madre embrionarias humanas.
HK1091508A1 (en) Skin regeneration system
EP1939278A4 (en) METHOD FOR PRODUCING A T CELL POPULATION
WO2007052172A3 (en) Methods for fusion polypeptide delivery into a cell
WO2006047743A8 (en) Swine multipotent adult progenitor cells
WO2006107850A3 (en) Preventing rejection of transplanted tissue using regulatory t cells
WO2007130612A3 (en) Method for obtaining and storing multipotent stem cells
SI1743029T1 (sl) Priprava celic
WO2003072728A3 (en) Cellular trans-differentiation
BR112022003852A2 (pt) Métodos de preparação de células t para terapia de células t
WO2010135639A3 (en) Compositions and methods for promoting beta cell maturity
EP3984596A4 (en) POPULATION OF CELLS COMPRISING MESENCHYMATOUS CELLS, PHARMACEUTICAL COMPOSITION COMPRISING THEM AND METHOD FOR PRODUCTION THEREOF
WO2006032054A3 (en) Differentiation of human mesenchymal stem cells to cardiac progenitor cells that promote cardiac repair
WO2008153962A3 (en) Method of reducing tissue loss in pancreatic islet cell transplantation
WO2006041651A3 (en) Fuel sources, fuel cells and methods of operating fuel cells
WO2007121438A3 (en) Cell therapy: a method and a composition for treating diabetes
BR9407682A (pt) Linhas de célula de secreçao de insulina métodos de produçao e uso